Universal Health International Group Holding Management
Management criteria checks 4/4
Universal Health International Group Holding's CEO is Chuanfu Chu, appointed in Aug 2021, has a tenure of 4.33 years. total yearly compensation is CN¥499.00K, comprised of 78.2% salary and 21.8% bonuses, including company stock and options. directly owns 0.72% of the company’s shares, worth HK$1.54M. The average tenure of the management team and the board of directors is 9 years and 11.3 years respectively.
Key information
Chuanfu Chu
Chief executive officer
CN¥499.0k
Total compensation
| CEO salary percentage | 78.16% |
| CEO tenure | 4.3yrs |
| CEO ownership | 0.7% |
| Management average tenure | 9yrs |
| Board average tenure | 11.3yrs |
Recent management updates
Recent updates
We Discuss Why The CEO Of Universal Health International Group Holding Limited (HKG:2211) Is Due For A Pay Rise
Dec 04
Universal Health International Group Holding Limited's (HKG:2211) Shares Bounce 28% But Its Business Still Trails The Industry
Sep 25Improved Revenues Required Before Universal Health International Group Holding Limited (HKG:2211) Stock's 36% Jump Looks Justified
Jul 15There's No Escaping Universal Health International Group Holding Limited's (HKG:2211) Muted Revenues Despite A 42% Share Price Rise
May 26Universal Health International Group Holding (HKG:2211) Shareholders Should Be Cautious Despite Solid Earnings
Apr 04Universal Health International Group Holding Limited (HKG:2211) Stock Catapults 28% Though Its Price And Business Still Lag The Industry
Mar 06Universal Health International Group Holding Limited's (HKG:2211) Price Is Right But Growth Is Lacking After Shares Rocket 75%
Dec 18How Much Is Universal Health International Group Holding Limited (HKG:2211) CEO Getting Paid?
Jan 13
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2025 | CN¥499k | CN¥390k | -CN¥26m |
| Mar 31 2025 | n/a | n/a | -CN¥6m |
| Dec 31 2024 | n/a | n/a | CN¥13m |
| Sep 30 2024 | n/a | n/a | CN¥7m |
| Jun 30 2024 | CN¥521k | CN¥411k | CN¥413k |
| Mar 31 2024 | n/a | n/a | -CN¥41m |
| Dec 31 2023 | n/a | n/a | -CN¥82m |
| Sep 30 2023 | n/a | n/a | -CN¥94m |
| Jun 30 2023 | CN¥518k | CN¥411k | -CN¥105m |
| Mar 31 2023 | n/a | n/a | -CN¥106m |
| Dec 31 2022 | n/a | n/a | -CN¥106m |
| Sep 30 2022 | n/a | n/a | -CN¥147m |
| Jun 30 2022 | CN¥470k | CN¥377k | -CN¥188m |
Compensation vs Market: Chuanfu's total compensation ($USD70.58K) is below average for companies of similar size in the Hong Kong market ($USD233.92K).
Compensation vs Earnings: Chuanfu's compensation has been consistent with company performance over the past year.
CEO
Chuanfu Chu (55 yo)
Mr. Chuanfu Chu serves as Chief Executive Officer & Executive Director of Universal Health International Group Holding Limited since August 1, 2021, serves as its Chief Operation Officer and serves as its...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, COO & Executive Chairman | 4.3yrs | CN¥499.00k | 0.72% HK$ 1.5m | |
| VP & Executive Vice Chairman | 13.8yrs | CN¥504.00k | 0.052% HK$ 111.9k | |
| GM of Finance & Executive Director | 14.2yrs | CN¥475.00k | 0.065% HK$ 139.6k | |
| Company Secretary | 2.3yrs | no data | no data |
Experienced Management: 2211's management team is seasoned and experienced (9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, COO & Executive Chairman | 4.3yrs | CN¥499.00k | 0.72% HK$ 1.5m | |
| VP & Executive Vice Chairman | 13.8yrs | CN¥504.00k | 0.052% HK$ 111.9k | |
| GM of Finance & Executive Director | 10.5yrs | CN¥475.00k | 0.065% HK$ 139.6k | |
| Independent Non-Executive Director | 12.1yrs | CN¥164.00k | 0.0045% HK$ 9.6k | |
| Independent Non-Executive Director | 12.1yrs | CN¥164.00k | 0.0045% HK$ 9.6k | |
| Independent Non-Executive Director | 8.4yrs | CN¥164.00k | 0.0045% HK$ 9.6k |
Experienced Board: 2211's board of directors are seasoned and experienced ( 11.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/06 13:12 |
| End of Day Share Price | 2025/12/05 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2025/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Universal Health International Group Holding Limited is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yue-Kwong Lui | CGS International |
| Manmohan Singh | CLSA |
| Bin Li | Morgan Stanley |